Posted on November 24th, 2014
Dan joined Advaxis in January 2013 as Senior Vice President, Chief Legal and Business Development Officer, was promoted to Executive Vice President in May 2013, and was appointed President and Chief Executive Officer of Advaxis in August 2013.
Company OverviewAdvaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete antigen/adjuvant fusion protein(s) designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS-HPV is being evaluated in Phase 1 and Phase 2 clinical trials for HPV-associated diseases including invasive cervical cancer, HPV-associated head and neck cancer, and anal cancer. Over fifteen (15) distinct constructs are in various stages of development, developed directly by the Company and through strategic collaborations with recognized centers of excellence. ... Learn More »
With Thanksgiving fast approaching (wasn’t it just summer?), I would like to take a moment to salute the extremely har...Read More »
Posted on November 20th, 2014
It is with great pleasure that I greet you all from DirectView’s offices here in New York City. What follows is a ...Read More »
Posted on November 19th, 2014
As the Chief Visionary Officer and a Director of NeoStem, and as one of the inventors of the core technology on which Ne...Read More »
Posted on November 18th, 2014
Yesterday, Dr. Arshed Quyyumi of Emory University presented initial Phase 2 data from our PreSERVE-AMI trial at the Amer...Read More »
Posted on November 13th, 2014
Hello, and welcome back to those of you who’ve followed our company in recent months. In case you’ve missed it, we h...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »